Section 118E:10R - Coverage for noninvasive prenatal screening(a) For the purposes of this section, "noninvasive prenatal screening" shall mean a cell-free DNA prenatal screening to ascertain if a pregnancy has a risk of fetal chromosomal aneuploidy; provided, however, that such screening shall include, but not be limited to, an analysis of chromosomes 13, 18 and 21.(b) The division and its contracted health insurers, health plans, health maintenance organizations, behavioral health management firms and third-party administrators under contract to a Medicaid managed care organization or primary care clinician shall provide coverage under all benefit plans for noninvasive prenatal screening and shall not limit availability and coverage for such screening based on the age of the pregnant patient or any other risk factor, unless the limitation is part of the generally accepted standards of professional practice as recommended by the American College of Obstetricians and Gynecologists. Mass. Gen. Laws ch. 118E, § 118E:10R
Added by Acts 2024, c. 186,§ 41, eff. 11/21/2024.